EUVIMEDEUVIMED entdecken
Crossref

Anxiolytic-like action of 3-((4-methoxyphenyl)selanyl)-2-phenylbenzofuran (SeBZF3) in mice: A possible contribution of the serotonergic system

Larissa Sander Magalhães, Dianer Nornberg Strelow, Mariana Parron Paim, Taís da Silva Teixeira Rech, Letícia Devantier Krüger, Antonio Luiz Braga, José Sebastião Santos Neto, César Augusto Brüning, Cristiani Folharini Bortolatto

Pharmacology Biochemistry and Behavior · 2023

DOI: 10.1016/j.pbb.2023.173651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2023. Verfasst von Larissa Sander Magalhães und 8 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-graduação em Bioquímica e Bioprospecção, Laboratório de Bioquímica e Neurofarmacologia Molecular (LABIONEM), Centro de Ciências Quími…. Hauptthemen laut MEDLINE: Anti-Anxiety Agents, Benzofurans, Anxiety, Serotonin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anxiety disorders, characterized by high prevalence rates, cause psychiatric disabilities and are related to impairments in serotoninergic system function. Frequent anxiety recurrence, resistance, and drug adverse effects have driven searches for new therapies. We initially evaluated the anxiolytic-like activity of 3-selanyl-benzo[b]furan compounds (SeBZF1-5) (50 mg/kg, i.g.) in male Swiss mice using the light-dark test (LDT). The compound 3-((4-methoxyphenyl)selanyl)-2-phenylbenzofuran (SeBZF3) exhibited anxiolytic-like activity. SeBZF3 anxiolytic-like effects were also observed in the novelty-suppressed feeding test (NSFT) (50 mg/kg) and elevated plus-maze test (EPMT) (25 and 50 mg/kg). In the EPMT, anxiolytic-like effects of SeBZF3 (50 mg/kg) were abolished by pretreatment with p-chlorophenylalanine, a selective tryptophan hydroxylase inhibitor (100 mg/kg, i.p. for 4 days), suggesting the involvement of serotonergic mechanisms. Furthermore, we conducted experiments to investigate the synergistic effects of SeBZF3 subeffective doses (5 mg/kg, i.g.) in combination with fluoxetine (a selective serotonin reuptake inhibitor, 5 mg/kg, i.p.) or buspirone (a partial agonist of the 5-HT1A receptor, 2 mg/kg, i.p.). This coadministration resulted in pronounced synergistic effects. We also examined the effects of repeated oral treatment with SeBZF3 at doses of 1 and 5 mg/kg over 14 days and both reduced anxiety signals. In vitro and ex vivo findings revealed that SeBZF3 inhibited cerebral MAO-A activity. These findings collectively imply the potential involvement of serotonergic mechanisms in the anxiolytic-like activity of SeBZF3 in mice. These data offer contributions to the research field of organoselenium compounds and anxiolytics, encouraging the broadening of the search for new effective drugs while offering improved side effect profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Anxiety AgentsBenzofuransAnxietySerotoninAnimalsMiceMaleBehavior, AnimalFenclonineFluoxetine

Stichwörter der Autor:innen

AnxietyBenzofuranSeBZF3SeleniumSerotonergic system

Substanzen

Anti-Anxiety AgentsBenzofuransSerotoninFenclonineFluoxetine

Autor:innen und Institutionen

  • Programa de Pós-graduação em Bioquímica e Bioprospecção, Laboratório de Bioquímica e Neurofarmacologia Molecular (LABIONEM), Centro de Ciências Químicas, Farmacêuticas e de Alimentos (CCQFA), Universidade Federal de Pel…
  • Programa de Pós-graduação em Química (PPGQ), Laboratório de Síntese de Derivados de Selênio e Telúrio (LabSelen), Departamento de Química, Universidade Federal de Santa Catarina, CEP 88040- 900 Florianópolis, Santa Cata…
  • Instituto de Química - Universidade Federal de Goiás (UFG), CEP 74690-900 Goiânia, Goiás, Brazil.

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
  • Universidade Federal de Pelotas

Zitieren

APA

Magalhães, L. S., Strelow, D. N., Paim, M. P., Rech, T. D. S. T., Krüger, L. D., Braga, A. L., Neto, J. S. S., Brüning, C. A., & Bortolatto, C. F. (2023). Anxiolytic-like action of 3-((4-methoxyphenyl)selanyl)-2-phenylbenzofuran (SeBZF3) in mice: A possible contribution of the serotonergic system. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2023.173651

Vancouver

Magalhães LS, Strelow DN, Paim MP, Rech TDST, Krüger LD, Braga AL, et al. Anxiolytic-like action of 3-((4-methoxyphenyl)selanyl)-2-phenylbenzofuran (SeBZF3) in mice: A possible contribution of the serotonergic system. Pharmacology Biochemistry and Behavior. 2023. doi:10.1016/j.pbb.2023.173651

BibTeX
@article{Magalhes2023,
  author = {Magalhães, Larissa Sander and Strelow, Dianer Nornberg and Paim, Mariana Parron and Rech, Taís da Silva Teixeira and Krüger, Letícia Devantier and Braga, Antonio Luiz and Neto, José Sebastião Santos and Brüning, César Augusto and Bortolatto, Cristiani Folharini},
  title = {Anxiolytic-like action of 3-((4-methoxyphenyl)selanyl)-2-phenylbenzofuran (SeBZF3) in mice: A possible contribution of the serotonergic system},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2023},
  doi = {10.1016/j.pbb.2023.173651}
}
Kostenlos starten →